Cargando…

Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity

PURPOSE: Among other emerging amyloid-targeting blood-based biomarkers, Multimer Detection System-Oligomeric Amyloid-β (MDS-OAβ) measures dynamic changes in concentration of oligomeric amyloid-β (OAβ), which is considered the main pathogenic culprit of Alzheimer’s disease (AD), in plasma after spiki...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pyun, Jung-Min, Ryu, Ji Sun, Lee, Ryan, Shim, Kyu Hawn, Youn, Young Chul, Ryoo, Nayoung, Han, Sang-Won, Park, Young Ho, Kang, Sungmin, An, Seong Soo A, Kim, SangYun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096417/ https://www.ncbi.nlm.nih.gov/pubmed/33958861 http://dx.doi.org/10.2147/CIA.S312473

Ejemplares similares

Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
por: Pyun, Jung-Min, et al.
Publicado: (2023)

Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-β oligomerization data
por: Youn, Young Chul, et al.
Publicado: (2022)

Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status
por: Babapour Mofrad, Rosha, et al.
Publicado: (2021)

Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
por: Youn, Young Chul, et al.
Publicado: (2019)

Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
por: Yang, YoungSoon, et al.
Publicado: (2018)

Erratum: Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
por: Yang, YoungSoon, et al.
Publicado: (2023)

Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ(42)
por: An, Seong Soo A., et al.
Publicado: (2017)

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
por: Wang, Min Jeong, et al.
Publicado: (2017)

Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2017)

Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer’s disease
por: Meng, Xue, et al.
Publicado: (2019)

(11)C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn, Young Chul, et al.
Publicado: (2017)

Predictive Scale for Amyloid PET Positivity Based on Clinical and MRI Variables in Patients with Amnestic Mild Cognitive Impairment
por: Chun, Min Young, et al.
Publicado: (2022)

Aminostyrylbenzofuran Directly Reduces Oligomeric Amyloid-β and Reverses Cognitive Deficits in Alzheimer Transgenic Mice
por: Lee, Sang-Hyun, et al.
Publicado: (2014)

Amyloid β Oligomeric Species Present in the Lag Phase of Amyloid Formation
por: Wolff, Martin, et al.
Publicado: (2015)

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease
por: Shim, Kyu Hwan, et al.
Publicado: (2022)

Predicting amyloid PET and tau PET stages with plasma biomarkers
por: Jack, Clifford R, et al.
Publicado: (2023)

Multimer Detection System-Oligomerized Amyloid Beta (MDS-OAβ): A Plasma-Based Biomarker Differentiates Alzheimer's Disease from Other Etiologies of Dementia
por: Dominguez, Jacqueline Cotoong, et al.
Publicado: (2022)

Coping with Dementia in the Middle of the COVID-19 Pandemic
por: Ryoo, Nayoung, et al.
Publicado: (2020)

Prediction of amyloid β PET positivity using machine learning in patients with suspected cerebral amyloid angiopathy markers
por: Jung, Young Hee, et al.
Publicado: (2020)

Dysregulated expression levels of APH1B in peripheral blood are associated with brain atrophy and amyloid-β deposition in Alzheimer’s disease
por: Park, Young Ho, et al.
Publicado: (2021)

Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson’s Disease
por: Shim, Kyu Hwan, et al.
Publicado: (2021)

Classification of Aβ State From Brain Amyloid PET Images Using Machine Learning Algorithm
por: Simfukwe, Chanda, et al.
Publicado: (2023)

Corrigendum: Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson's Disease
por: Shim, Kyu Hwan, et al.
Publicado: (2021)

Characterization of the Oligomerization and Aggregation of Human Serum Amyloid A
por: Patke, Sanket, et al.
Publicado: (2013)

Ultrafast propagation of β-amyloid fibrils in oligomeric cloud
por: Ogi, Hirotsugu, et al.
Publicado: (2014)

Structural mapping of oligomeric intermediates in an amyloid assembly pathway
por: Karamanos, Theodoros K, et al.
Publicado: (2019)

Oligomerization by co-assembly of β-amyloid and α-synuclein
por: Kim, Jin Ryoun
Publicado: (2023)

Concordance in detecting amyloid positivity between (18)F-florbetaben and (18)F-flutemetamol amyloid PET using quantitative and qualitative assessments
por: Cho, Soo Hyun, et al.
Publicado: (2020)

PET-validated EEG-machine learning algorithm predicts brain amyloid pathology in pre-dementia Alzheimer’s disease
por: Kim, Nam Heon, et al.
Publicado: (2023)

Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease
por: Pan, Xiao-dong, et al.
Publicado: (2011)

5-Hydroxycyclopenicillone Inhibits β-Amyloid Oligomerization and Produces Anti-β-Amyloid Neuroprotective Effects In Vitro
por: Zhao, Jiaying, et al.
Publicado: (2017)

Extracellular vesicles: where the amyloid precursor protein carboxyl‐terminal fragments accumulate and amyloid‐β oligomerizes
por: Pérez‐González, Rocío, et al.
Publicado: (2020)

Plasmonic nanoparticle amyloid corona for screening Aβ oligomeric aggregate-degrading drugs
por: Lee, Dongtak, et al.
Publicado: (2021)

The accuracy and robustness of plasma biomarker models for amyloid PET positivity
por: Benedet, Andréa L., et al.
Publicado: (2022)

Author Correction: Concordance in detecting amyloid positivity between (18)F-florbetaben and (18)F-flutemetamol amyloid PET using quantitative and qualitative assessments
por: Cho, Soo Hyun, et al.
Publicado: (2021)

Hydroxytyrosol Inhibits Protein Oligomerization and Amyloid Aggregation in Human Insulin
por: Sirangelo, Ivana, et al.
Publicado: (2020)

Polymorphic SERPINA3 prolongs oligomeric state of amyloid beta
por: Akbor, Maruf Mohammad, et al.
Publicado: (2021)

Amyloid-β oligomerization monitored by single-molecule stepwise photobleaching
por: Dresser, Lara, et al.
Publicado: (2021)

Editorial: Oligomerization and fibrillation of amyloid peptides: Mechanism, toxicity and inhibition
por: Qian, Zhenyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_48ojpnj7jl6jn8t3dua96qoaki